Literature DB >> 9685613

Fibronectin-binding activity in Borrelia burgdorferi1.

D J Grab1, C Givens, R Kennedy.   

Abstract

Recently, the term MSCRAMM (microbial surface components recognizing adhesive matrix molecules), has been introduced to describe microbial molecules that recognize extracellular matrix (ECM) [1]. Here we present evidence for the presence of fibronectin-binding molecules in Borrelia burgdorferi and several other Borrelia species. Immunofluorescence studies show that plasma fibronectin is bound uniformly over the cell surface of free swimming B. burgdorferi. In addition, the spirochetes are able to bind to plasma fibronectin-coated microwell plates, an interaction that is inhibited by anti-fibronectin antibody as well as exogenous plasma fibronectin. Taken together, the data suggest that fibronectin binds to the surface of the spirochete. On Western blot-like assays, B. burgdorferi and some B. afzelii strains express a major fibronectin-binding protein (Fn-BA) with an approximate molecular mass of 52 kDa. In addition, several other major Fn-BAs were found in B. hermsii (26, 31, 33, 39, 46, 54 and 58 kDa) and B. turicatae (39, 41, 45, 50, 56, 59 and 66 kDa). Preliminary evidence suggests that fibronectin (and Fn-BA) may play a role as a molecular bridge between the spirochete and other components of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685613     DOI: 10.1016/s0925-4439(98)00038-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans.

Authors:  Joshua R Fischer; Kimberly T LeBlanc; John M Leong
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Allelic variation of the Lyme disease spirochete adhesin DbpA influences spirochetal binding to decorin, dermatan sulfate, and mammalian cells.

Authors:  Vivian M Benoit; Joshua R Fischer; Yi-Pin Lin; Nikhat Parveen; John M Leong
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

3.  Delineation of Borrelia burgdorferi p66 sequences required for integrin alpha(IIb)beta(3) recognition.

Authors:  G Defoe; J Coburn
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains.

Authors:  Sharon Lederer; Christiane Brenner; Thomas Stehle; Lise Gern; Reinhard Wallich; Markus M Simon
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

5.  Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.

Authors:  Angela M Floden; Tammy Gonzalez; Robert A Gaultney; Catherine A Brissette
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

6.  Borrelia burgdorferi BmpA is a laminin-binding protein.

Authors:  Ashutosh Verma; Catherine A Brissette; Amy Bowman; Brian Stevenson
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

7.  Borrelia burgdorferi RevA antigen binds host fibronectin.

Authors:  Catherine A Brissette; Tomasz Bykowski; Anne E Cooley; Amy Bowman; Brian Stevenson
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

8.  A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin.

Authors:  Mary Beth Brinkman; Melanie A McGill; Jonas Pettersson; Arthur Rogers; Petra Matejková; David Smajs; George M Weinstock; Steven J Norris; Timothy Palzkill
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

9.  Treponema pallidum fibronectin-binding proteins.

Authors:  Caroline E Cameron; Elizabeth L Brown; Janelle M Y Kuroiwa; Lynn M Schnapp; Nathan L Brouwer
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

10.  The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin.

Authors:  Yi-Pin Lin; Yung-Fu Chang
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.